Single-arm salvage therapy with pegylated interferon alfa-2a for patients with high-risk polycythemia vera or high-risk essential thrombocythemia who are either hydroxyurea-resistant or intolerant: Final results of the Myeloproliferative Disorders-Research Consortium (MPD-RC) Protocol 111 global phase II trial Meeting Abstract
| Authors: | Yacoub, A.; Mascarenhas, J.; Kosiorek, H. E.; Prchal, J. T.; Berenzon, D.; Baer, M. R.; Ritchie, E. K.; Silver, R. T.; Kessler, C. M.; Winton, E. F.; Finazzi, M. C.; Rambaldi, A.; Vannucchi, A. M.; Leibowitz, D. S.; Rondelli, D.; Arcasoy, M. O.; Catchatourian, R.; Vadakara, J.; Rosti, V.; Hexner, E.; Kremyanskaya, M.; Orellana, A.; Sandy, L.; Tripodi, J.; Najfeld, V.; Salama, M. E.; Weinberg, R. S.; Rampal, R. K.; Mesa, R. A.; Goldberg, J. D.; Dueck, A. C.; Hoffman, R. |
| Abstract Title: | Single-arm salvage therapy with pegylated interferon alfa-2a for patients with high-risk polycythemia vera or high-risk essential thrombocythemia who are either hydroxyurea-resistant or intolerant: Final results of the Myeloproliferative Disorders-Research Consortium (MPD-RC) Protocol 111 global phase II trial |
| Meeting Title: | 59th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 130 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2017 Dec 9-12 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2017-12-07 |
| Language: | English |
| ACCESSION: | WOS:000432419400376 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V130.Suppl_1.321.321 |
| Notes: | Meeting Abstract: 321 -- Source: Wos |
